Suchergebnisse - "Yoshihara, Kazutaka"

PubPharm (29)

1

Exposure-response analysis of the efficacy and safety of esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with or without diabetic kidney disease

enthalten in: Drug metabolism and pharmacokinetics | 2024

von Yoshihara, K. | Fukae, M. | Kastrissios, H. | +2

2

HER2 - THERAPY FOR DRUG-RESISTANT CANCER BY ADMINISTRATION OF ANTI-HER2 ANTIBODY/DRUG CONJUGATE

enthalten in: Europäisches Patentamt | 2023

von JIKOH TAKAHIRO | OGITANI YUSUKE | YOSHIHARA KAZUTAKA | +2

3

HER2 - THERAPY FOR DRUG-RESISTANT CANCER BY ADMINISTRATION OF ANTI-HER2 ANTIBODY/DRUG CONJUGATE

enthalten in: Europäisches Patentamt | 2023

von JIKOH TAKAHIRO | OGITANI YUSUKE | YOSHIHARA KAZUTAKA | +2

4

Trastuzumab Deruxtecan Dosing in Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer : Population Pharmacokinetic Modeling and Exposure-Response Analysis

enthalten in: Journal of clinical pharmacology | 2023

von Yoshihara, K. | Kobayashi, Y. | Endo, S. | +6

5

Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants

enthalten in: Clinical pharmacology in drug development | 2023

von Toyama, K. | Eto, T. | Suzuki, K. | +4

6

Population pharmacokinetics of esaxerenone, a novel non-steroidal mineralocorticoid receptor blocker, in patients with essential hypertension, patients with diabetic nephropathy, and healthy volunteers

enthalten in: Drug metabolism and pharmacokinetics | 2023

von Yoshihara, K. | Fukae, M. | Kastrissios, H. | +3

7

DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 : Results from a phase 2 clinical study

enthalten in: Vaccine | 2023

von Toyama, K. | Eto, T. | Takazawa, K. | +10

8

THERAPY FOR DRUG-RESISTANT CANCER BY ADMINISTRATION OF ANTI-HER2 ANTIBODY/DRUG CONJUGATE

enthalten in: Europäisches Patentamt | 2023

von JIKOH TAKAHIRO | OGITANI YUSUKE | YOSHIHARA KAZUTAKA | +2

9

Trastuzumab Deruxtecan Dosing in Human Epidermal Growth Factor Receptor 2‐Positive Gastric Cancer : Population Pharmacokinetic Modeling and Exposure–Response Analysis

enthalten in: The Journal of Clinical Pharmacology | 2023

von Yoshihara, K. | Kobayashi, Y. | Endo, S. | +6

10

Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2-Positive Breast Cancer and Other Solid Tumors

enthalten in: Clinical pharmacology and therapeutics | 2021

von Yin, O. | Xiong, Y. | Endo, S. | +5